BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

MLA

Rassidakis, George Z., et al. “BCL-2 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin Disease Predicts a Poorer Prognosis in Patients Treated with ABVD or Equivalent Regimens.” Blood, vol. 100, no. 12, Dec. 2002, pp. 3935–41. EBSCOhost, https://doi.org/10.1182/blood.V100.12.3935.

APA

Rassidakis, G. Z., Medeiros, L. J., Vassilakopoulos, T. P., Viviani, S., Bonfante, V., Nadali, G., Herling, M., Angelopoulou, M. K., Giardini, R., Chilosi, M., Kittas, C., McDonnell, T. J., Bonadonna, G., Gianni, A. M., Pizzolo, G., Pangalis, G. A., Cabanillas, F., & Sarris, A. H. (2002). BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. Blood, 100(12), 3935–3941. https://doi.org/10.1182/blood.V100.12.3935

Chicago

Rassidakis, George Z., L. Jeffrey Medeiros, Theodoros P. Vassilakopoulos, Simonetta Viviani, Valeria Bonfante, Gianpaolo Nadali, Marco Herling, et al. 2002. “BCL-2 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin Disease Predicts a Poorer Prognosis in Patients Treated with ABVD or Equivalent Regimens.” Blood 100 (12): 3935–41. doi:10.1182/blood.V100.12.3935.